LYEL compared with SPTX: revenue, margins and what each company keeps, and the suppliers and customers both name

LYELLyell Immunopharma, Inc.

Mkt capRevenueRevenue

SPTXSeaport Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LYELLyell Immunopharma, Inc.

SPTXSeaport Therapeutics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

LYELwithSPTX

No shared trading history for LYEL and SPTX.

Shared co-movers: not yet measured (LYEL, SPTX).

LYEL, solidSPTX, hatchedr = correlationBar = r to r 0.75Source: daily closes

LYELLyell Immunopharma, Inc.

10.69▼−3.14%· post 10.69· delayed

Mkt cap$270.5MRevenue$4,000Q2 FY26Revenue$36,000FY25

SPTXSeaport Therapeutics, Inc.

19.73▲+0.64%· post 19.73· delayed

After hoursNov 2 '26delayed

Mkt cap$690.6MRevenue—Revenue—

Compare

After hoursNov 2 '26delayed

LYELLyell Immunopharma, Inc.

SPTXSeaport Therapeutics, Inc.

10.69▼−3.14%post 10.69delayed

Price

19.73▲+0.64%post 19.73delayed

$270.5M

Mkt cap

$690.6M

Q2 FY26$4,000

Revenue

—

FY25$36,000

Revenue

—

LYEL10.69▼−3.14%vsSPTX19.73▲+0.64%After hoursNov 2 '26delayed